AnheuserBusch InBev Shares Dip After Quarterly Sales Fall Short of Analyst Expectations CLGN Q4 2025 Earnings EPS Misses Estimates as Biotech Continues PreRevenue Phase Angeion Halts Vendor Rebates as Class Action Administration Faces Kickback Scrutiny